骨桥蛋白促胃癌侵袭转移机制的研究进展

Abstract
Figure/Table
References (33)
Related Citation (15)

Download: PDF (622 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Osteopontin (OPN) is a phosphorylated glycoprotein that is highly expressed in a variety of cancers, which has the effects of inhibiting tumor cell apoptosis and promoting tumor cell invasion and metastasis. In recent years, studies have demonstrated that OPN is overexpressed in gastric cancer and it can up-regulate the expression of various angiogenic factors and protein kinases through MAPK, NF-κB, PI3K/AKT signaling pathways, autocrine pathways, and macrophage polarization. The overexpression of OPN promotes the invasion and metastasis of gastric cancer cells. Therefore, OPN may become a new target for regulating the invasion and metastasis of gastric cancer cells. This paper analyzes and summarizes the mechanism of OPN in promoting the invasion and metastasis of gastric cancer, in order to provide reference for the treatment of OPN target of gastric cancer.

Key words： Osteopontin Gastric cancer Invasion Metastasis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIN Yuechao1 YUAN Xiaolin1 QU Fanjie2

Cite this article:

QIN Yuechao1 YUAN Xiaolin1 QU Fanjie2. Research progress on the mechanism of osteopontin in promoting the invasion and metastasis of gastric cancer[J]. 中国医药导报, 2018, 15(36): 28-31,39.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I36/28

[1] Zhang J，Pan Q，Yan W，et al. Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis [J]. Oncol Lett，2018，15（5）：7776-7782.
[2] Oyama M，Kariya Y，Kariya Y，et al. Biological role of site-specific O-glycosylation in cell adhesion activity and phosphorylation ofosteopontin [J]. Biochem J，2018，475（9）：1583-1595.
[3] Wen Y，Wang C，Gu J，et al. Metabolic modulation of acetaminophen-induced hepatotoxicity by osteopontin [J]. Cell Mol Immunol，2018. [Epub ahead of print]
[4] Cao DX，Li ZJ，Jiang XO，et al. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers [J]. World J Gastroenterol，2012，18（30）：3923-3930.
[5] Jin X，Zhu Z，Shi Y. Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis [J]. Bull Cancer，2014，101（1）：E1-E12.
[6] Chen X，Sun X，Wang Z，et al. Involvement of acid-sensing ion channel 1a in gastric carcinoma cell migration and invasion [J]. Acta Biochim Biophys Sin，2018，50（5）：440-446.
[7] Tsai CY，Wang CS，Tsai MM，et al. Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis [J]. Clin Cancer Res，2014，20（9）：2276-2288.
[8] Xu YH，Li ZL，Qiu SF，et al. IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling [J]. Transl Oncol，2018，11（1）：182-192.
[9] Cui H，Hu Y，Guo D，et al. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer [J]. Oncogene，2018.
[10] Xu C，Li H，Yin M，et al. Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis [J]. Oncotarget，2017，8（58）：98394-98404.
[11] Wong JPC，Wei R，Lyu P，et al. Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer [J]. Int J Biol Sci，2017，13（11）：1373-1386.
[12] Di Bartolomeo M，Pietrantonio F，Pellegrinelli A，et al. Osteopontin，E-cadherin，and beta-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer [J]. Gastric Cancer，2016，19（2）：412-420.
[13] Lee SH，Park JW，Go DM，et al. Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice [J]. Carcinogenesis，2015，36（12）：1550-1560.
[14] Liu F，Bai C，Guo Z. The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism [J]. Oncotarget，2017，8（41）：70084-70096.
[15] Imano M，Satou T，Itoh T，et al. Immunohistochemical Expression of Osteopontin in Gastric Cancer [J]. J Gastrointest Surg，2009，13（9）：1577-1582.
[16] Dai N，Bao Q，Lu A，et al. Protein Expression of Osteopontin in Tumor Tissues Is an Independent Prognostic Indicator in Gastric Cancer [J]. Oncology，2007，72（1/2）：89-96.
[17] Higashiyama M，Ito T，Tanaka E，et al. Prognostic Significance of Osteopontin Expression in Human Gastric Carcinoma [J]. Ann Surg Oncol，2007，14（12）：3419-3427.
[18] Sui H，Wang K，Xie R，et al. NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization [J]. Oncotarget，2017，8（21）：34516-34524.
[19] Gong M，Lu Z，Fang G，et al. A small interfering RNA targeting osteopontin as gastric cancer therapeutics [J]. Cancer Lett，2008，272（1）：148-159.
[20] Wang ZM，Cui YH，Li W，et al. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells [J]. Oncol Rep，2011，25（4）：997-1003.
[21] Chakraborty G，Jain S，Kundu GC. Osteopontin Promotes Vascular Endothelial Growth Factor-Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Par-acrine Mechanisms [J]. Cancer Res，2008，68（1）：152-161.
[22] Yang G，Zhang Y，Wu J，et al. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells [J]. Mol Med Rep，2011，4（6）：1169-1173.
[23] Ramchandani D，Weber GF. Interactions between osteopontin and vascular endothelial growth factor：implications for cancer [J]. Biochim Biophys Acta，2015，1855（2）：202-222.
[24] Wu XL，Lin KJ，Bai AP，et al. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells [J]. World J Gastroenterol，2014，20（30）：10440-10448.
[25] 王立岩，王雪，郝筱诗，等.OPN基因抑制对宫颈癌Hela细胞生长侵袭影响与VEGF和MMP-2关系[J].临床医药文献电子杂志，2015，2（7）：1217-1218.
[26] Wang L，Cossette SM，Rarick KR，et al. Correction：Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo [J]. PLoS One，2013，8（12）：e0137369.
[27] 张岚，李海玉，殷晓璐，等.骨桥蛋白下游信号分子在肝细胞癌中的表达[J].中华肝脏病杂志，2011，19（1）：48-51.
[28] Liu J，Liu Q，Wan Y，et al. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K [J]. Int J Oncol，2014， 45（1）：282-290.
[29] Ahmadian E，Khosroushahi AY，Eftekhari，et al. A Novel angiotensin receptor blocker，azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2 [J]. Biomed Pharmacother，2018，99：939-946.
[30] Matsuoka T，Yashiro M. The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma [J]. Cancers，2014，6（3）：1441-1463.
[31] Zhang H，Guo M，Chen J，et al. Osteopontin Knockdown Inhibits αvβ3 Integrin-Induced Cell Migration and Invasion and Promotes Apoptosis of Breast Cancer Cells by Inducing Autophagy and Inactivating the PI3K/Akt/mTOR Pathway [J]. Cell Physiol Biochem，2014，33（4）：991-1002.
[32] Lin CN，Wang CJ，Chao YJ，et al. The significance of the co-existence of osteopontin and tumor-associated macr-ophages in gastric cancer progression [J]. BMC Cancer，2015，15（15）：128
[33] Huang J，Pan C，Hu H，et al. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells [J]. PLoS One，2012，7（10）：e47901.